Vivani Medical VANI
NASDAQ VANI
$1.38 -0.03 (-2.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Vivani Medical (VANI) Total Debt (2020 - 2021)

Vivani Medical (VANI) posted quarterly Total Debt of $2.2 million for Q1 2021, little changed quarter-over-quarter from $2.2 million in Q4 2020.

Vivani Medical (VANI) Total Debt (2020 - 2021) Analysis & Trends

Vivani Medical's Total Debt history runs 2 years deep, the most recent figure standing at $2.2 million for Q1 2021.

  • In Q1 2021, Total Debt changed N/A year-over-year to $2.2 million; the TTM figure through Mar 2021 stood at $2.2 million (changed N/A YoY), while the FY2020 annual figure was $2.2 million, changed N/A from the prior year.
  • Total Debt for Q1 2021 stood at $2.2 million, roughly flat from $2.2 million in the prior quarter.
  • The five-year high for Total Debt was $2.2 million in Q4 2020, with the low at $2.2 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 770.36 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.34 Bn
10 Vivani Medical 120.18 Mn 100.29 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 2.20 Mn
Dec 31, 2020 2.20 Mn